Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder

Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS). This is the first trial of a unique oral contraceptive containing a combination of drospirenone (DRSP, 3 mg) and ethinyl estradiol (EE, 30 microg) for the treatment of PMDD. DRSP is a spironolactone-like progesti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of women's health & gender-based medicine 2001-07, Vol.10 (6), p.561-569
Hauptverfasser:	Freeman, E W, Kroll, R, Rapkin, A, Pearlstein, T, Brown, C, Parsey, K, Zhang, P, Patel, H, Foegh, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adaptation, Psychological Adolescent Adult Androstenes - therapeutic use Contraceptives, Oral, Combined - therapeutic use Depression - drug therapy Depression - psychology Double-Blind Method Ethinyl Estradiol - therapeutic use Female Humans Menstrual Cycle Premenstrual Syndrome - drug therapy Premenstrual Syndrome - psychology Treatment Outcome United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!